Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
2005 1
2010 5
2011 3
2017 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II).
Danese S, Vermeire S, Hellstern P, Panaccione R, Rogler G, Fraser G, Kohn A, Desreumaux P, Leong RW, Comer GM, Cataldi F, Banerjee A, Maguire MK, Li C, Rath N, Beebe J, Schreiber S. Danese S, et al. Among authors: maguire mk. Gut. 2019 Jan;68(1):40-48. doi: 10.1136/gutjnl-2017-314562. Epub 2017 Dec 15. Gut. 2019. PMID: 29247068 Free PMC article. Clinical Trial.
A multicenter, randomized, open-label, pharmacokinetics and safety study of pantoprazole tablets in children and adolescents aged 6 through 16 years with gastroesophageal reflux disease.
Ward RM, Kearns GL, Tammara B, Bishop P, O'Gorman MA, James LP, Katz MH, Maguire MK, Rath N, Meng X, Comer GM. Ward RM, et al. Among authors: maguire mk. J Clin Pharmacol. 2011 Jun;51(6):876-87. doi: 10.1177/0091270010377501. Epub 2010 Sep 17. J Clin Pharmacol. 2011. PMID: 20852004 Free PMC article. Clinical Trial.
Pharmacodynamics and safety of pantoprazole in neonates, preterm infants, and infants aged 1 through 11 months with a clinical diagnosis of gastroesophageal reflux disease.
Kierkus J, Furmaga-Jablonska W, Sullivan JE, David ES, Stewart DL, Rath N, Fu C, Wang W, Maguire MK, Comer GM. Kierkus J, et al. Among authors: maguire mk. Dig Dis Sci. 2011 Feb;56(2):425-34. doi: 10.1007/s10620-010-1321-3. Epub 2010 Jul 7. Dig Dis Sci. 2011. PMID: 20607405 Clinical Trial.
Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD.
Winter H, Kum-Nji P, Mahomedy SH, Kierkus J, Hinz M, Li H, Maguire MK, Comer GM. Winter H, et al. Among authors: maguire mk. J Pediatr Gastroenterol Nutr. 2010 Jun;50(6):609-18. doi: 10.1097/MPG.0b013e3181c2bf41. J Pediatr Gastroenterol Nutr. 2010. PMID: 20400912 Clinical Trial.
Randomized, open-label, multicentre pharmacokinetic studies of two dose levels of pantoprazole granules in infants and children aged 1 month through <6 years with gastro-oesophageal reflux disease.
Tammara BK, Sullivan JE, Adcock KG, Kierkus J, Giblin J, Rath N, Meng X, Maguire MK, Comer GM, Ward RM. Tammara BK, et al. Among authors: maguire mk. Clin Pharmacokinet. 2011 Aug;50(8):541-50. doi: 10.2165/11591900-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21740077 Clinical Trial.
Do not ignore the physician in discharge planning.
Kerstein MD, Baker RC, Maguire MK. Kerstein MD, et al. Among authors: maguire mk. NLN Publ. 1985 Jun;(20-1977):79-82. NLN Publ. 1985. PMID: 3849715 No abstract available.